Parexel Intl Cp (PRXL) 67.41 $PRXL PAREXEL Appoints Four

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Parexel Intl Cp (PRXL) 67.41 $PRXL

PAREXEL Appoints Four Executives to Senior Leadership Team
BusinessWire - Mon Aug 01, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of four company executives to its senior-most leadership team, the Business Review Committee:
PRXL: 67.41 (+0.56)

SmarTrend Watching for Potential Rebound in Shares of Parexel International After 2.64% Loss
Comtex SmarTrend(R) - Mon Jul 18, 3:22PM CDT
Parexel International (NASDAQRXL) traded in a range yesterday that spanned from a low of $63.69 to a high of $65.33. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $65.56 on volume of 355,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PRXL: 67.41 (+0.56)

PAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2016 Earnings Release and Conference Call
BusinessWire - Mon Jul 11, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for Fourth Quarter and Fiscal Year 2016 on Wednesday, August 3, 2016 after the close of the stock market.
PRXL: 67.41 (+0.56)

PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
BusinessWire - Mon Jun 20, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia.
PRXL: 67.41 (+0.56)

PAREXEL Invites Public to Listen to Live Webcast of Investor Day Presentations on June 30
BusinessWire - Wed Jun 15, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day presentations on Thursday, June 30, 2016, from 9:00 a.m. to 12:00 p.m. EDT.
PRXL: 67.41 (+0.56)

PAREXEL Announces Master Services Agreement with Pfizer
BusinessWire - Fri Jun 10, 1:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical development programs across its portfolio. Terms of the agreement were not disclosed.
PRXL: 67.41 (+0.56)

PAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from the American Business Awards
BusinessWire - Thu Jun 02, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year - Pharmaceuticals in the 14th Annual American Business Awards(SM). The judges awarded PAREXEL a Gold Stevie(R) Award and recognized the Company's investments in innovation and expanded capabilities across the drug development continuum in 2015 as specifics for the accolade.
PRXL: 67.41 (+0.56)

PAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare Conference
BusinessWire - Tue May 24, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June.
PRXL: 67.41 (+0.56)

PAREXEL International to Present at UBS Healthcare Conference
BusinessWire - Mon May 09, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Tuesday, May 24, 2016, in New York City. Ingo Bank, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL and discussing business developments at 8:30 a.m. ET.
PRXL: 67.41 (+0.56)

The Zacks Analyst Blog Highlights: Newell Brands, Hormel Foods, Shire and PAREXEL International
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:30AM CDT
The Zacks Analyst Blog Highlights: Newell Brands, Hormel Foods, Shire and PAREXEL International
PRXL: 67.41 (+0.56), NWL: 53.97 (+1.51), SHPG: 194.00 (-0.12), HRL: 37.55 (+0.20)

Parexel meets 3Q profit forecasts
Automated Insights - Wed Apr 27, 3:47PM CDT
WALTHAM, Mass. (AP) _ Parexel International Corp. (PRXL) on Wednesday reported fiscal third-quarter profit of $47.9 million.
PRXL: 67.41 (+0.56)

PAREXEL International Reports Third Quarter Fiscal Year 2016 Results
BusinessWire - Wed Apr 27, 3:01PM CDT
--Adjusted operating margin of 13.3%; GAAP operating margin of 13.2%
PRXL: 67.41 (+0.56)

The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
AIRM: 32.70 (-0.59), PRXL: 67.41 (+0.56), EBS: 30.97 (-2.42), CRL: 88.44 (+0.51), MOH: 56.16 (-0.65)

4 Stocks to Avoid Sell-in-May Syndrome
Swarup Gupta - Zacks Investment Research - Wed Apr 27, 8:25AM CDT
Picking stocks from defensive sectors like consumer staples and healthcare may be a smarter option.
PRXL: 67.41 (+0.56), NWL: 53.97 (+1.51), SHPG: 194.00 (-0.12), HRL: 37.55 (+0.20)

What's in Store for TrovaGene (TROV) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:16AM CDT
TrovaGene Inc. (TROV) is expected to release first-quarter 2016 results on May 3.
BDX: 176.78 (+0.78), PRXL: 67.41 (+0.56), ALGN: 89.69 (+0.54), TROV: 5.58 (-0.05)

Will Ecolab's (ECL) Earnings Surprise Investors in Q1?
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 7:51AM CDT
Ecolab Inc. (ECL) is slated to announce first-quarter 2016 earnings results on May 3.
BDX: 176.78 (+0.78), PRXL: 67.41 (+0.56), ALGN: 89.69 (+0.54), ECL: 118.67 (+0.29)

Nutrisystem (NTRI) Q1 Earnings: Can the Stock Surprise?
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 7:47AM CDT
Nutrisystem Inc. (NTRI) is scheduled to release first-quarter 2016 results on May 3.
BDX: 176.78 (+0.78), PRXL: 67.41 (+0.56), ALGN: 89.69 (+0.54), NTRI: 29.54 (-0.04)

Myriad Genetics (MYGN) Q3 Earnings: A Beat in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 2:27PM CDT
Last quarter, Myriad (MYGN) posted a positive earnings surprise of 9.76%.
ZBH: 131.06 (-0.08), MYGN: 31.48 (+0.50), PRXL: 67.41 (+0.56), GILD: 80.46 (+0.99)

5 Stocks to Invest on Healthcare Rebound
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 10:42AM CDT
Healthcare stocks bounced back this month after being mostly out of favor during the first quarter.
AIRM: 32.70 (-0.59), PRXL: 67.41 (+0.56), EBS: 30.97 (-2.42), CRL: 88.44 (+0.51), MOH: 56.16 (-0.65)

Henry Schein (HSIC) Q1 Earnings: Can the Stock Surprise?
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 8:07AM CDT
Last quarter, Henry Schein (HSIC) posted a positive earnings surprise of 1.21%
ZBH: 131.06 (-0.08), PRXL: 67.41 (+0.56), GILD: 80.46 (+0.99), HSIC: 180.14 (-0.84)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 69

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 255

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 69

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 136

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 131

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact

Updated Category News Views 148

A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....

Continue Reading
Fold Health's AI: Revolutionizing Patient Care Dynamics

Updated Category News Views 140

AI's Role in Healthcare: From Insight to Action Healthcare's got a resource issue, plain and simple. It's like trying to fill a bathtub with a hole in it—clinicians are swamped, burnout is high, and patients aren't getting the attention they need. Enter Fold Health's AI operating layer, launched with the ambition to realign the equation. Not Just Another Tech Buzzword...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 63

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
Monotype Unveils Font Tool for Adobe: A Game-Changer?

Updated Category News Views 165

Monotype Connect: Fonts Meet Convenience Imagine fighting through a blizzard with a flashlight. That's how designers juggle fonts without a central tool. Well, Monotype's got them covered with the new Connect panel for Adobe apps—a beacon of efficiency spotted at Adobe MAX 2026 in Miami Beach. Efficiency and Brand Unity: Partners in Design Now, here’s why this isn’t...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 120

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Insights from OncoHost in Lung Cancer Treatment Strategy

Updated Category News Views 149

New Advances in Understanding Lung Cancer Treatment Resistance Recent findings from OncoHost shed light on the mechanisms behind resistance to immunotherapy in patients battling lung cancer. The study presents vital insights aimed at improving therapeutic strategies through advanced plasma proteomics analysis. Insights from Advanced Plasma Proteomics OncoHost, a...

Continue Reading
Understanding Eldorado Gold's Current Market Position and P/E

Updated Category News Views 167

Analyzing Eldorado Gold Inc's Current Market Situation At present, Eldorado Gold Inc. (NYSE: EGO) shares trade at a price of $27.34, reflecting a decrease of 5.85% in the current session. This decline comes after a slight drop of 1.19% over the past month. Despite this short-term volatility, when looking over a longer timeline, the stock shows impressive growth, having...

Continue Reading
Truecaller Achieves Remarkable Growth with 450 Million Users

Updated Category News Views 218

Truecaller Reaches 450 Million Monthly Active Users Truecaller, the renowned platform dedicated to verifying contacts and blocking unwanted communications, has reached a significant milestone, surpassing 450 million active users. This achievement marks another step in its impressive growth trajectory over the last year, with around 50 million new users added in just ten...

Continue Reading
Shell plc's Recent Share Buybacks: Key Insights Revealed

Updated Category News Views 377

Overview of Shell plc's Share Buyback Activities Shell plc has recently initiated significant share buyback activities as part of its ongoing strategy to enhance shareholder value. This move demonstrates the company's commitment to investing back into itself and optimizing capital allocation. The buybacks reflect Shell's strong financial position and positive outlook on...

Continue Reading
Wyndham Hotels Investigation: Uncovering Potential $50 Million Loss

Updated Category News Views 324

Investigation into Wyndham Hotels Sparks Concern Recent findings from internal records of Wyndham Hotels & Resorts have revealed alarming information suggesting that the Royalton Letter of Credit (LOC) was fully funded but not released. This situation raises troubling questions about potential securities and franchise-law violations involving multiple parties....

Continue Reading